"As the cornerstone of the Chesapeake Regional Healthcare family of services, Chesapeake Regional Medical Center has 310 private beds, arranged in special nursing units to provide the best possible care for our patients. The hospital is a major health resource for southeastern Virginia and northeastern North Carolina residents."

During the past decade, Chesapeake General Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Chesapeake General Hospital" are "Arterial Occlusive Diseases" (1 trials), "Carotid Artery Disease" (1 trials), "Graft Occlusion, Vascular" (1 trials), "Hyperplasia" (1 trials) and "Ischemia" (1 trials). Many other conditions were trialed in "Chesapeake General Hospital" in a lesser frequency.

Most popular intervention types in "Chesapeake General Hospital" are "Device" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "CGT003 (E2F Duplex Decoy)" (1 trials) and "Xact Stent with either Emboshield Pro (Gen 5) or Emboshield (Gen 3)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Chesapeake General Hospital" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Chesapeake General Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Chesapeake General Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Chesapeake General Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".